CAPRICOR THERAPEUTICS, INC. Other Current Liabilities
CAPRICOR THERAPEUTICS, INC. (CAPR) had Other Current Liabilities of $27.48 thousand as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-03-11
- 2023-12-31: Other Liabilities, Current $27.48K.
- 2023-09-30: Other Liabilities, Current $20.18K.
- 2022-12-31: Other Liabilities, Current $89.23K.
| Period end | Other Liabilities, Current |
|---|---|
| 2023-12-31 | $27.48K 10-K · filed 2024-03-11 |
| 2023-09-30 | $20.18K 10-Q · filed 2023-11-14 |
| 2022-12-31 | $89.23K 10-K · filed 2024-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |